
TNG908
CAS No. 2760481-53-4
TNG908( —— )
Catalog No. M36534 CAS No. 2760481-53-4
TNG908 is an orally active and selective MTAP-co-PRMT5 inhibitor that crosses the blood-brain barrier and kills MTAP-deficient cancers.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 476 | Get Quote |
![]() ![]() |
5MG | 645 | Get Quote |
![]() ![]() |
10MG | 1007 | Get Quote |
![]() ![]() |
25MG | 1518 | Get Quote |
![]() ![]() |
50MG | 2006 | Get Quote |
![]() ![]() |
100MG | 2520 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameTNG908
-
NoteResearch use only, not for human use.
-
Brief DescriptionTNG908 is an orally active and selective MTAP-co-PRMT5 inhibitor that crosses the blood-brain barrier and kills MTAP-deficient cancers.
-
DescriptionTNG908 is a MTAP-cooperative PRMT5 inhibitor that can pass through the blood-brain barrier. TNG908 is 15 times more selective for MTAP null cell lines than MTAPWT cell lines, and can be used in cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorHistone Methyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2760481-53-4
-
Formula Weight409.51
-
Molecular FormulaC21H23N5O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (244.20 mM; Ultrasonic )
-
SMILESC(C(NC=1C=C(C)C(N)=NC1)=O)(=O)N2[C@H](CC[C@H](C)C2)C=3C=C4C(=CC3)SC=N4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. K. Briggs, et al. TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor for the treatment of MTAP-deleted cancer.MOLECULAR TARGETED AGENTS 2
?VOLUME 174, SUPPLEMENT 1,?S84,?OCTOBER 2022.
?VOLUME 174, SUPPLEMENT 1,?S84,?OCTOBER 2022.
molnova catalog



related products
-
Lomibuvir
Lomibuvir (VCH-222) is a selective, non-nucleoside allosteric inhibitor of HCV NS5B polymerase (RdRp) with a Kd of 17 nM. Lomibuvir inhibits the 1b/Con1 HCV subgenomic replicon with an EC 50 of 5.2 nM.
-
Alclofenac
Alclofenac has a significant effect on the acute phase protein response and the degree of L-tryptophan binding to plasma protein and can be used in the treatment of patients with chronic rheumatism.
-
Ellagic acid 4-O-alp...
The roots of Diplopanax stachyanthus.